These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 304258)

  • 1. Isolation of antithrombin III from normal and alpha1-antitrypsin-deficient human plasma.
    Borsodi AD; Bradshaw RA
    Thromb Haemost; 1977 Aug; 38(2):475-85. PubMed ID: 304258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of human pancreatic proteinases by human plasma alpha2-antiplasmin and antithrombin.
    Nobar SM; Guy-Crotte O; Rabaud M; Bieth JG
    Biol Chem; 2004 May; 385(5):423-7. PubMed ID: 15196003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-1-antitrypsin deficiency in children: liver disease is not reflected by low serum levels of alpha-1-antitrypsin - a study on 48 pediatric patients.
    Lang T; Mühlbauer M; Strobelt M; Weidinger S; Hadorn HB
    Eur J Med Res; 2005 Dec; 10(12):509-14. PubMed ID: 16356865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bothrops jararaca antithrombin: isolation, characterization and comparison with other animal antithrombins.
    de Morais KB; Vieira CO; Hirata IY; Tanaka-Azevedo AM
    Comp Biochem Physiol B Biochem Mol Biol; 2009 Feb; 152(2):171-6. PubMed ID: 19049827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse effect of heparin in thrombin-antithrombin III interaction.
    Marciniak E
    Thromb Diath Haemorrh; 1975 Dec; 34(3):748-62. PubMed ID: 1209544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Electrophoretic mobility of antithrombin III in an agarose gel with heparin. (author's transl)].
    Aiach M; Fiessinger JN; Andreux JP; Beuvin J; Housset E; Leclerc M
    Pathol Biol (Paris); 1977 Dec; 25 Suppl():35-41. PubMed ID: 353657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Danazol-induced augmentation of serum alpha 1-antitrypsin levels in individuals with marked deficiency of this antiprotease.
    Gadek JE; Fulmer JD; Gelfand JA; Frank MM; Petty TL; Crystal RG
    J Clin Invest; 1980 Jul; 66(1):82-87. PubMed ID: 6967489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin cofactor II determination--levels in normals and patients with hereditary antithrombin III deficiency and disseminated intravascular coagulation.
    Tran TH; Duckert F
    Thromb Haemost; 1984 Oct; 52(2):112-6. PubMed ID: 6395434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The different forms of antithrombin II in serum.
    Pepper DS; Banhegyi D; Cash JD
    Thromb Haemost; 1977 Aug; 38(2):494-503. PubMed ID: 579491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of antithrombin III from human plasma: its separation from alpha1-antitrypsin1.
    Burrowes CE; Movat HZ
    Biochem Biophys Res Commun; 1977 Jan; 74(1):140-9. PubMed ID: 300021
    [No Abstract]   [Full Text] [Related]  

  • 11. Fate of thrombin and thrombin-antithrombin-III complex adsorbed to a heparinized biomaterial: analysis of the enzyme-inhibitor complexes displaced by plasma.
    Hatton MW; Rollason G; Sefton MV
    Thromb Haemost; 1983 Dec; 50(4):873-7. PubMed ID: 6198746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Procedures for the isolation and characterization of human antithrombin III].
    Trobisch H; Wüst T; Rustige H
    Behring Inst Mitt; 1986 Feb; (79):177-90. PubMed ID: 3718405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated factor Xa activity in the blood of asymptomatic patients with congenital antithrombin deficiency.
    Bauer KA; Goodman TL; Kass BL; Rosenberg RD
    J Clin Invest; 1985 Aug; 76(2):826-36. PubMed ID: 3875633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
    Jørgensen M; Petersen LC; Thorsen S
    J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Panniculitis revealing qualitative alpha 1 antitrypsine deficiency (MS variant).
    Loche F; Tremeau-Martinage C; Laplanche G; Massip P; Bazex J
    Eur J Dermatol; 1999; 9(7):565-7. PubMed ID: 10523739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GAGs-potentiated inhibition of thrombin, factor Xa and plasmin in plasma and in a purified system containing antithrombin III - correlation with total charge density.
    Cofrancesco E; Vigo A; Pogliani EM
    Thromb Haemost; 1981 Dec; 46(4):749-51. PubMed ID: 6460339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombin III Avranches, a new variant with defective serine-protease inhibition--comparison with antithrombin III Charleville.
    Aiach M; Roncato M; Chadeuf G; Dezellus P; Capron L; Fiessinger JN
    Thromb Haemost; 1988 Aug; 60(1):94-6. PubMed ID: 3187951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic modulation of thrombin generation associated with human clots by human purified antithrombin alone or in the presence of low molecular weight heparin or unfractionated heparin.
    Meddahi S; Bara L; Fessi H; Samama MM
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):51-9. PubMed ID: 10691099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of alpha1-antitrypsin in the inclusion bodies from the liver in alpha 1-antitrypsin deficiency.
    Jeppsson JO; Larsson C; Eriksson S
    N Engl J Med; 1975 Sep; 293(12):576-9. PubMed ID: 168490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further investigations on antithrombin III in the plasmas of patients with the abnormality of antithrombin III Budapest.
    Sas G; Pepper DS; Cash JD
    Thromb Diath Haemorrh; 1975 Jun; 33(3):564-72. PubMed ID: 1154312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.